For BRCA1, we identified ‘breast carcinoma’, ‘prostate carcinoma’, and ‘malignant neoplasm of pancreas’ as top candidate diseases (Fig. 3d), which were all validated by the literature29, 30, 31. This evidence concerns the gene BRCA1 and prostate carcinoma.